Synergistic Composition for Drug Sensitization and Therapy in Cancer
Implementing Organization
Indian Institute of Chemical Engineers
Indian Institute of Chemical Technology (IICT)
About
Tested in orthotopic and humanoid models of various cancers in association with Mayo Clinic, USA
Patents
US8012952, US9364566, US9861653,
Outcome / Output
A glucocorticoid receptor (GR)-based platform technology: carries multiple drugs induces targeted drug sensitization, EMT-reversal and kills drug- resistant cancer cells and cancer stem cells (CSCs); hence, suited to also treat cancer relapse. The technology repurposes a typical cancer drugs against multiple cancers
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Indian Institute of Chemical Engineers
Acces sibility Controls